Amiodarone is a potassium channel blocking agent indicated for life-threatening supraventricular and ventricular arrythmias (Baritussio et al. 2001), but the use of this drug is associated with significant toxic effects against lung tissue, primarily the development of pulmonary fibrosis. Here, KCNA3 is linked to pulmonary fibrosis.